- Home
- DOUG vs STIM Comparison
DOUG vs STIM Comparison
Compare DOUG & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOUG
- STIM
- Stock Information
- Founded
- DOUG 1911
- STIM 2003
- Country
- DOUG United States
- STIM United States
- Employees
- DOUG N/A
- STIM N/A
- Industry
- DOUG Building operators
- STIM Medical/Dental Instruments
- Sector
- DOUG Real Estate
- STIM Health Care
- Exchange
- DOUG Nasdaq
- STIM Nasdaq
- Market Cap
- DOUG 225.3M
- STIM 224.8M
- IPO Year
- DOUG N/A
- STIM 2018
- Fundamental
- Price
- DOUG $2.73
- STIM $3.10
- Analyst Decision
- DOUG
- STIM Strong Buy
- Analyst Count
- DOUG 0
- STIM 2
- Target Price
- DOUG N/A
- STIM $7.00
- AVG Volume (30 Days)
- DOUG 382.3K
- STIM 1.1M
- Earning Date
- DOUG 11-03-2025
- STIM 11-04-2025
- Dividend Yield
- DOUG N/A
- STIM N/A
- EPS Growth
- DOUG N/A
- STIM N/A
- EPS
- DOUG N/A
- STIM N/A
- Revenue
- DOUG $1,034,406,000.00
- STIM $111,106,000.00
- Revenue This Year
- DOUG $17.61
- STIM $105.70
- Revenue Next Year
- DOUG N/A
- STIM $11.77
- P/E Ratio
- DOUG N/A
- STIM N/A
- Revenue Growth
- DOUG 8.69
- STIM 54.17
- 52 Week Low
- DOUG $1.48
- STIM $0.52
- 52 Week High
- DOUG $3.20
- STIM $5.92
- Technical
- Relative Strength Index (RSI)
- DOUG 52.07
- STIM 56.25
- Support Level
- DOUG $2.46
- STIM $2.61
- Resistance Level
- DOUG $2.89
- STIM $3.23
- Average True Range (ATR)
- DOUG 0.13
- STIM 0.20
- MACD
- DOUG 0.01
- STIM 0.05
- Stochastic Oscillator
- DOUG 69.81
- STIM 79.20
About DOUG Douglas Elliman Inc.
Douglas Elliman Inc is a real estate company. It offers sales, rentals, and new development to mortgages and title insurance, among other services related to real estate. Business is engaged in two operating segments Real Estate Brokerage and Corporate and other. The firm generates income from Commission and other brokerage revenue from existing home sales, Commission and other brokerage income from development marketing, Property management revenue and Title fees. It derives revenue from Real Estate Brokerage segment.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.